Ferroptosis inhibitor ferrostatin-1 attenuates morphine tolerance development in male rats by inhibiting dorsal root ganglion neuronal ferroptosis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Ferrostatin-1 and liproxstatin-1, both ferroptosis inhibitors, protect cells. Liproxstatin-1 decreases morphine tolerance. Yet, ferrostatin-1's effect on morphine tolerance remains unexplored. This study aimed to evaluate the influence of ferrostatin-1 on the advancement of morphine tolerance and understand the underlying mechanisms in male rats. Methods: This experiment involved 36 adult male Wistar albino rats with an average weight ranging from 220 to 260 g. These rats were categorized into six groups: Control, single dose ferrostatin-1, single dose morphine, single dose ferrostatin-1 + morphine, morphine tolerance (twice daily for five days), and ferrostatin-1 + morphine tolerance (twice daily for five days). The antinociceptive action was evaluated using both the hot plate and tail-flick tests. After completing the analgesic tests, tissue samples were gathered from the dorsal root ganglia (DRG) for subsequent analysis. The levels of glutathione, glutathione peroxidase 4 (GPX4), and nuclear factor erythroid 2-related factor 2 (Nrf2), along with the measurements of total oxidant status (TOS) and total antioxidant status (TAS), were assessed in the tissues of the DRG. Results: After tolerance development, the administration of ferrostatin-1 resulted in a significant decrease in morphine tolerance (P < 0.001). Additionally, ferrostatin-1 treatment led to elevated levels of glutathione, GPX4, Nrf2, and TOS (P < 0.001), while simultaneously causing a decrease in TAS levels (P < 0.001). Conclusions: The study found that ferrostatin-1 can reduce morphine tolerance by suppressing ferroptosis and reducing oxidative stress in DRG neurons, suggesting it as a potential therapy for preventing morphine tolerance.
Abstract
Background: Ferrostatin-1 and liproxstatin-1, both ferroptosis inhibitors, protect cells. Liproxstatin-1 decreases morphine tolerance. Yet, ferrostatin-1's effect on morphine tolerance remains unexplored. This study aimed to evaluate the influence of ferrostatin-1 on the advancement of morphine tolerance and understand the underlying mechanisms in male rats. Methods: This experiment involved 36 adult male Wistar albino rats with an average weight ranging from 220 to 260 g. These rats were categorized into six groups: Control, single dose ferrostatin-1, single dose morphine, single dose ferrostatin-1 + morphine, morphine tolerance (twice daily for five days), and ferrostatin-1 + morphine tolerance (twice daily for five days). The antinociceptive action was evaluated using both the hot plate and tail-flick tests. After completing the analgesic tests, tissue samples were gathered from the dorsal root ganglia (DRG) for subsequent analysis. The levels of glutathione, glutathione peroxidase 4 (GPX4), and nuclear factor erythroid 2-related factor 2 (Nrf2), along with the measurements of total oxidant status (TOS) and total antioxidant status (TAS), were assessed in the tissues of the DRG. Results: After tolerance development, the administration of ferrostatin-1 resulted in a significant decrease in morphine tolerance (P < 0.001). Additionally, ferrostatin-1 treatment led to elevated levels of glutathione, GPX4, Nrf2, and TOS (P < 0.001), while simultaneously causing a decrease in TAS levels (P < 0.001). Conclusions: The study found that ferrostatin-1 can reduce morphine tolerance by suppressing ferroptosis and reducing oxidative stress in DRG neurons, suggesting it as a potential therapy for preventing morphine tolerance.
참고문헌 (50)
- de Guglielmo G, "Analgesic tolerance to morphine is regulated by PPARγ", Br J Pharmacol, 171, pp.5407~5416 (2014)
- Yadlapalli JSK, "Evaluation of analgesia, tolerance, and the mechanism of action of morphine-6-O-sulfate across multiple pain modalities in Sprague-Dawley rats", Anesth Analg, 125, pp.1021~1031 (2017)
- Wilson-Poe AR, "Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance", J Physiol, 595, pp.6541~6555 (2017)
- Trivedi M, "Morphine induces redox-based changes in global DNA methylation and retrotransposon transcription by inhibition of excitatory amino acid transporter type 3-mediated cysteine uptake", Mol Pharmacol, 85, pp.747~757 (2014)
- Yang B, "Unveiling anti-oxidative and anti-inflammatory effects of docosahexaenoic acid and its lipid peroxidation product on lipopolysaccharidestimulated BV-2 microglial cells", J Neuroinflammation, 15, pp.202~ (2018)
- Ward RJ, "The role of iron in brain ageing and neurodegenerative disorders", Lancet Neurol, 13, pp.1045~1060 (2014)
- Ghadery C, "R2* mapping for brain iron : associations with cognition in normal aging", Neurobiol Aging, 36, pp.925~932 (2015)
- Mancardi D, "Iron overload, oxidative stress, and ferroptosis in the failing heart and liver", Antioxidants (Basel), 10, pp.1864~ (2021)
- Yang WS, "Regulation of ferroptotic cancer cell death by GPX4", Cell, 156, pp.317~331 (2014)
- Skouta R, "Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models", J Am Chem Soc, 136, pp.4551~4556 (2014)
- Chen X, "Liproxstatin-1 attenuates morphine tolerance through inhibiting spinal ferroptosis-like cell death", ACS Chem Neurosci, 10, pp.4824~4833 (2019)
- Xie Y, "Ferroptosis : process and function", Cell Death Differ, 23, pp.369~379 (2016)
- Ubellacker JM, "Lymph protects metastasizing melanoma cells from ferroptosis", Nature, 585, pp.113~118 (2020)
- Bai L, "Thioredoxin-1 rescues MPP+", MPTP-induced ferroptosis by increasing glutathione peroxidase 4, 2021, pp.58, 3187~3197
- Miotto G, "Insight into the mechanism of ferroptosis inhibition by ferrostatin-1", Redox Biol, 28, pp.101328~ (2020)
- Ye Q, "Ferrostatin-1 mitigates cognitive impairment of epileptic rats by inhibiting P38 MAPK activation", Epilepsy Behav, 103, pp.106670~ (2020)
- Chu J, "Ferrostatin-1 protects HT-22 cells from oxidative toxicity", Neural Regen Res, 15, pp.528~536 (2020)
- Avcı O, "Anakinra, an interleukin-1 receptor antagonist, increases the morphine analgesic effect and decreases morphine tolerance development by modulating oxidative stress and endoplasmic reticulum stress in rats", Turk J Med Sci, 50, pp.2048~2058 (2020)
- Baser T, "Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in rats", Can J Physiol Pharmacol, 99, pp.461~467 (2021)
- Taştemur Y, "Role of dopaminergic system in oxytocin analgesia : the missing part in a puzzle", Trop J Pharm Res, 19, pp.1087~1092 (2020)
- Modi AD, "Evaluating pain behaviours : widely used mechanical and thermal methods in rodents", Behav Brain Res, 446, pp.114417~ (2023)
- Taskiran AS, "Effect of captopril, an angiotensin-converting enzyme inhibitor, on morphine analgesia and tolerance in rats, and elucidating the inflammation and endoplasmic reticulum stress pathway in this effect", Neurosci Lett, 741, pp.135504~ (2021)
- Taskiran AS, "The effects of proton pump inhibitors(pantoprazole)on pentylenetetrazole-induced epileptic seizures in rats and neurotoxicity in the SHSY5Y human neuroblastoma cell line", Cell Mol Neurobiol, 41, pp.173~183 (2021)
- Erel O, "A novel automated method to measure total antioxidant response against potent free radical reactions", Clin Biochem, 37, pp.112~119 (2004)
- Erel O, "A new automated colorimetric method for measuring total oxidant status", Clin Biochem, 38, pp.1103~1111 (2005)
- Dogan M, "Assessment of mechanism involved in the apoptotic and anti-cancer activity of Quercetin and Quercetin-loaded chitosan nanoparticles", Med Oncol, 39, pp.176~ (2022)
- Unal M, "Ineffective doses of dexmedetomidine potentiates the antinociception induced by morphine and fentanyl in acute pain model", Korean J Physiol Pharmacol, 17, pp.417~422 (2013)
- Shen L, "Ferroptosis in acute central nervous system injuries : the future direction", Front Cell Dev Biol, 8, pp.594~ (2020)
- Lee YS, "Ferroptosis-induced endoplasmic reticulum stress : cross-talk between ferroptosis and apoptosis", Mol Cancer Res, 16, pp.1073~1076 (2018)
- Alvarez SW, "NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis", Nature, 551, pp.639~643 (2017)
- Doll S, "Iron and ferroptosis : a still illdefined liaison", IUBMB Life, 69, pp.423~434 (2017)
- Lewerenz J, "Oxytosis", ferroptosis-(Re-)emerging roles for oxidative stress-dependent non-apoptotic cell death in diseases of the central nervous system, 2018, pp.12, 214~
- An S, "The effects of acrylamide-mediated dorsal root ganglion neurons injury on ferroptosis", Hum Exp Toxicol, 41, pp.9603271221129786~ (2022)
- Li Q, "Inhibition of neuronal ferroptosis protects hemorrhagic brain", JCI Insight, 2, pp.e90777~ (2017)
- Alim I, "Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke", Cell, 177, pp.1262~1279 (2019)
- Hervera A, "Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain : nitric oxide signaling", Mol Pain, 7, pp.25~ (2011)
- Bannon AW, "Models of nociception:hot-plate, tail-flick, and formalin tests in rodents", Curr Protoc Neurosci, Chapter 8, pp.Unit 8.9~ (2007)
- Piel MJ, "Pain assessment in animal models of osteoarthritis", Gene, 537, pp.184~188 (2014)
- Mitrovic I, "Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences", Proc Natl Acad Sci U S A, 100, pp.271~276 (2003)
- Pizzorno J, "Glutathione!", Integr Med (Encinitas), 13, pp.8~12 (2014)
- Cao JY, "Mechanisms of ferroptosis", Cell Mol Life Sci, 73, pp.2195~2209 (2016)
- Abdel-Zaher AO, "Inhibition of brain oxidative stress and inducible nitric oxide synthase expression by thymoquinone attenuates the development of morphine tolerance and dependence in mice", Eur J Pharmacol, 702, pp.62~70 (2013)
- Ma Q, "Role of nrf2 in oxidative stress and toxicity", Annu Rev Pharmacol Toxicol, 53, pp.401~426 (2013)
- Song X, "Nrf2 and ferroptosis : a new research direction for neurodegenerative diseases", Front Neurosci, 14, pp.267~ (2020)
- Reymond S, "Morphine-induced modulation of Nrf2-antioxidant response element signaling pathway in primary human brain microvascular endothelial cells", Sci Rep, 12, pp.4588~ (2022)
- Skrabalova J, "Morphine as a potential oxidative stress-causing agent", Mini Rev Org Chem, 10, pp.367~372 (2013)
- Zöllner C, "Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain", J Clin Invest, 118, pp.1065~1073 (2008)
- Blomqvist KJ, "Antagonism of peripheral opioid receptors by methylnaltrexone does not prevent morphine tolerance in rats", J Neurosci Res, 100, pp.329~338 (2022)
- Bartley EJ, "Sex differences in pain : a brief review of clinical and experimental findings", Br J Anaesth, 111, pp.52~58 (2013)
